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Figure S1. M1EVs as drug delivery systems to deliver cargo to the interior of cells. A. Confocal 
image showing M0 macrophages exposed to fluorescein (soluble dye) loaded vesicles exhibit 
fluorescence after 2 hours of interaction with fluorescein loaded vesicles. B. Confocal image of 
DiI-labelled M1EVs delivered to M0 macrophages after 2 hours of interaction showing clear 
















Figure S2. Quantification of cytokine expression my M0 macrophages when left to incubate the with 
M1EVs in vitro. Each data point is the average of at least 3 experiments. One-Way ANOVA was done 
to test the statistical significance of the results. The data are presented as the mean ± standard error 









Figure S3. Polarization of M2 macrophages towards M1 macrophages in vitro when treated with 
M1EVs. Each data point is the average of at least 3 experiments. One-Way ANOVA was done to test 






Figure S4. Quantification of pro-inflammatory cytokines present on M1EVs. M1EVs were 

























Figure S5. Polarization of M1 macrophages towards M2 macrophages in vitro when treated with 
M2EVs. Each data point is the average of at least 3 experiments. One-Way ANOVA was done to test 








Figure S6. Quantification of cytokine released by M1 microglia, M2 microglia and M2 microglia 
that were incubated with M1EVs. Each data point is the average of at least 3 experiments. The data 
are presented as the mean ± SEM. One-Way ANOVA was done to test the statistical significance of 
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Figure S7. Specificity of targeting of MEVs on macrophages and A549 cells. Each datapoint is 
the average of five independent replicates. Norm. ID is the mean integrated density of the image 
normalized to the mean integrated density value of macrophages prior to vesicles addition. The 
data are presented as the mean ± SEM (n=5). **P < 0.01 indicates a significant difference in the 
vesicle uptake by macrophages and A549 cells at respective time points. 
 
 
 
 
 
